NCT04499950 - Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

January 10, 2024

Study Completion Date

January 10, 2024

Conditions

Breast CancerOverweight or Obesity

Interventions

DRUG

Contrave

Initiate Contrave at 1 tab in morning (AM) for Week 9; then 1 tab in AM and 1 tab in evening (PM) for Week 10; then 2 tab in AM and 1 tab in PM for Week 11; then 2 tab in AM and 2 tab in PM for week 12; then constant dose for months 4-6.

BEHAVIORAL

Behavioral Weight Loss

6 months of behavioral weight loss. First 3 months are weekly calls with coach and then transition to monthly calls for months 4-6.

Trial Locations (1)

21231

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore